Aberrant Notch signalling was first linked to human cancer through the identification of a chromosome translocation, in T-cell acute lymphoblastic leukaemia (T-ALL), that resulted in the expression of the soluble cytoplasmic domain of Notch1, which was constitutively active, linking ectopic Notch activity to cancer progression [50]. The gene discussed is NOTCH1; the disease is cancer.